Mediwelcome Healthcare Management & Technology Inc. (HKG:2159)
Hong Kong
· Delayed Price · Currency is HKD 1.480
+0.020 (1.37%)
Apr 29, 2026, 3:15 PM HKT
HKG:2159 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Revenue | 468.02 | 321.56 | 331.31 | 323.37 | 708.36 | Upgrade
|
| Revenue Growth (YoY) | 45.55% | -2.94% | 2.45% | -54.35% | 63.86% | Upgrade
|
| Cost of Revenue | 373.31 | 270.55 | 301.41 | 290.82 | 614.76 | Upgrade
|
| Gross Profit | 94.71 | 51 | 29.9 | 32.55 | 93.6 | Upgrade
|
| Selling, General & Admin | 63.7 | 60.59 | 73.35 | 75.56 | 75.84 | Upgrade
|
| Research & Development | 27.94 | 18.68 | 32.69 | 50.61 | 18.7 | Upgrade
|
| Operating Expenses | 92.89 | 87.21 | 111.81 | 129.59 | 86.92 | Upgrade
|
| Operating Income | 1.82 | -36.21 | -81.92 | -97.04 | 6.67 | Upgrade
|
| Interest Expense | -1.44 | -1.09 | -1.3 | -1.25 | -1.26 | Upgrade
|
| Interest & Investment Income | 0.24 | 0.26 | 0.42 | 0.62 | 0.79 | Upgrade
|
| Currency Exchange Gain (Loss) | -2.33 | 0.73 | 0.48 | 2.79 | -0.77 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.09 | 0.19 | 3.17 | 2.47 | -0.86 | Upgrade
|
| EBT Excluding Unusual Items | -1.61 | -36.11 | -79.16 | -92.41 | 4.57 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.49 | 0.46 | 2.19 | 1.27 | 1.03 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.72 | -0.06 | -0.05 | - | -0.02 | Upgrade
|
| Asset Writedown | 9.26 | -11.68 | -20.45 | - | - | Upgrade
|
| Other Unusual Items | 0.56 | 2.21 | 1.09 | 0.1 | - | Upgrade
|
| Pretax Income | 6.98 | -45.17 | -96.38 | -91.04 | 5.59 | Upgrade
|
| Income Tax Expense | - | 1.78 | -0.29 | 2.71 | 0.39 | Upgrade
|
| Earnings From Continuing Operations | 6.98 | -46.95 | -96.09 | -93.74 | 5.2 | Upgrade
|
| Minority Interest in Earnings | 3.01 | 1.7 | 2 | 4.54 | -0.56 | Upgrade
|
| Net Income | 9.99 | -45.25 | -94.1 | -89.2 | 4.65 | Upgrade
|
| Net Income to Common | 9.99 | -45.25 | -94.1 | -89.2 | 4.65 | Upgrade
|
| Net Income Growth | - | - | - | - | -77.92% | Upgrade
|
| Shares Outstanding (Basic) | 228 | 191 | 191 | 186 | 181 | Upgrade
|
| Shares Outstanding (Diluted) | 228 | 191 | 191 | 186 | 182 | Upgrade
|
| Shares Change (YoY) | 19.12% | - | 3.03% | 1.98% | 21.48% | Upgrade
|
| EPS (Basic) | 0.04 | -0.24 | -0.49 | -0.48 | 0.03 | Upgrade
|
| EPS (Diluted) | 0.04 | -0.24 | -0.49 | -0.48 | 0.03 | Upgrade
|
| EPS Growth | - | - | - | - | -81.82% | Upgrade
|
| Free Cash Flow | - | -15.02 | -76.98 | -19.87 | -2.06 | Upgrade
|
| Free Cash Flow Per Share | - | -0.08 | -0.40 | -0.11 | -0.01 | Upgrade
|
| Gross Margin | 20.24% | 15.86% | 9.02% | 10.07% | 13.21% | Upgrade
|
| Operating Margin | 0.39% | -11.26% | -24.73% | -30.01% | 0.94% | Upgrade
|
| Profit Margin | 2.13% | -14.07% | -28.40% | -27.58% | 0.66% | Upgrade
|
| Free Cash Flow Margin | - | -4.67% | -23.24% | -6.14% | -0.29% | Upgrade
|
| EBITDA | 3.43 | -34.6 | -79.32 | -93.79 | 11.32 | Upgrade
|
| EBITDA Margin | 0.73% | -10.76% | -23.94% | -29.00% | 1.60% | Upgrade
|
| D&A For EBITDA | 1.61 | 1.61 | 2.6 | 3.25 | 4.65 | Upgrade
|
| EBIT | 1.82 | -36.21 | -81.92 | -97.04 | 6.67 | Upgrade
|
| EBIT Margin | 0.39% | -11.26% | -24.73% | -30.01% | 0.94% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 6.91% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.